在使用罗沙司他进行透析的情况下，低胆固醇水平是中枢性甲状腺功能减退的良好标志物。
Low cholesterol levels are good markers for central hypothyroidism in case with dialysis using roxadustat.
作者信息
Kita Serina, Okuyama Hiroshi, Kondo Takaya, Hayashi Mizuki, Nakao Shinichiro, Sawamura Toshitaka, Fujimoto Keiji, Nakagawa Atsushi, Yokoyama Hitoshi, Furuichi Kengo
机构信息
Department of Nephrology Kanazawa Medical University Kahoku-gun Japan.
Asanogawa General Hospital Kanazawa Japan.
出版信息
Clin Case Rep. 2024 Sep 3;12(9):e9400. doi: 10.1002/ccr3.9400. eCollection 2024 Sep.
Recently, hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors have been used for renal anemia, but side effects have also been reported. We report on the association of central hypothyroidism and cholesterol with roxadustat. Based on this case and previous reports, we believe that patients receiving roxadustat should have their thyroid function and cholesterol levels checked regularly.
最近，缺氧诱导因子脯氨酰羟化酶（HIF-PH）抑制剂已被用于治疗肾性贫血，但也有副作用的报道。我们报告了中枢性甲状腺功能减退和胆固醇与罗沙司他的关联。基于该病例及先前报道，我们认为接受罗沙司他治疗的患者应定期检查甲状腺功能和胆固醇水平。
Zotero 插件